Oral NVB Metronomic

Phase 2Small molecule

Sanofi

Oral NVB Metronomic is one of 30 small molecule programs targeting Poliomyelitis. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PoliomyelitisActive, not recruiting

Breast CancerActive, not recruiting

PoliomyelitisPhase 2

Active, not recruiting

Breast CancerPhase 2

Active, not recruiting

Competition

Competitive Landscape

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

Tecentriq

Roche

Preclinical

36 2

Tykerb

GSK

Preclinical

80 3

Prolia

Amgen

Preclinical

14 4

DATROWAY

Daiichi Sankyo

Preclinical

4 5

Blenoxane

Bristol-Myers Squibb

Preclinical

1 6

Zolymbus

AbbVie

Preclinical

1 7

Oral NVB Metronomic

Sanofi

Phase 2

2 8

Nubain

AAultman Health Foundation

Preclinical

1 9

Zoladex

Luye Pharma Group Ltd.

Preclinical

8 10

Neoadjuvant Treatment

SShanghai Zhongshan Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Breast Cancer2 trials

A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast Cancer

Unknown status·CChinese Academy of Medical Sciences·Phase 2·NCT03854617·172 enrolled

Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer

Unknown status·CChinese Academy of Medical Sciences·Phase 2·NCT04452370·100 enrolled

Poliomyelitis1 trial

The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV)

Completed·CChinese Academy of Medical Sciences·Phase 2·NCT01056705·500 enrolled

Vaccine1 trial

Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants

Completed· Sanofi logo

Sanofi·Phase 3·NCT00348881·2,133 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Oral NVB Metronomic. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Oral NVB Metronomic compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Oral NVB Metronomic. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sanofi company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: Sanofi

Oral NVB Metronomic

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Breast Cancer2 trials

Poliomyelitis1 trial

Vaccine1 trial

References

Drug Info

Quick Facts

Related News